佛慈制药
(002644)
| 流通市值：43.97亿 | | | 总市值：43.97亿 |
| 流通股本：5.11亿 | | | 总股本：5.11亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 384,119,508.08 | 386,336,618.95 | 397,893,224.19 | 351,622,449.61 |
| 应收票据及应收账款 | 426,418,270.12 | 365,285,040.98 | 376,688,186.67 | 343,973,094.8 |
| 其中：应收票据 | 88,032,040.23 | 39,110,167.82 | 68,049,181.58 | - |
| 应收账款 | 338,386,229.89 | 326,174,873.16 | 308,639,005.09 | 343,973,094.8 |
| 应收款项融资 | 36,620,776.83 | 51,667,856.51 | 36,884,461.7 | 45,395,807.46 |
| 预付款项 | 15,386,203.07 | 7,273,820.62 | 9,530,840.22 | 16,980,207.27 |
| 其他应收款合计 | 23,259,047.02 | 26,048,029.3 | 32,205,213.98 | 37,249,690.65 |
| 存货 | 352,833,168.29 | 313,464,384.14 | 339,991,996.73 | 405,498,888.06 |
| 其他流动资产 | 33,631,316.02 | 28,852,060.56 | 28,690,157.97 | 25,861,114.36 |
| 流动资产合计 | 1,272,268,289.43 | 1,178,927,811.06 | 1,221,884,081.46 | 1,226,581,252.21 |
| 非流动资产: | | | | |
| 长期股权投资 | 51,741,397.14 | 54,501,844.05 | 55,663,345.27 | 57,546,825.06 |
| 投资性房地产 | 7,096,938.7 | 7,619,337.48 | 7,305,898.21 | 7,803,812.61 |
| 固定资产 | 1,004,149,811.85 | 1,024,892,594.2 | 1,028,543,483.45 | 1,021,858,630.11 |
| 在建工程 | 1,764,636.34 | 1,764,636.34 | 1,764,636.34 | 3,789,261.28 |
| 使用权资产 | 1,445,720.08 | 1,528,226.61 | 1,703,185.51 | 1,597,488.33 |
| 无形资产 | 75,287,209.05 | 76,065,226.84 | 76,866,361.82 | 77,653,093.2 |
| 商誉 | 9,009,586.84 | 9,009,586.84 | 9,009,586.84 | 9,009,586.84 |
| 长期待摊费用 | 2,222,209.46 | 1,627,816.5 | 3,756,694.1 | 5,981,476.88 |
| 递延所得税资产 | 63,329,018.26 | 62,863,496.66 | 61,809,926.77 | 53,832,447.09 |
| 其他非流动资产 | 2,134,557.29 | 1,970,908.3 | 1,478,108.3 | 5,931,102.7 |
| 非流动资产合计 | 1,218,181,085.01 | 1,241,843,673.82 | 1,247,901,226.61 | 1,245,003,724.1 |
| 资产总计 | 2,490,449,374.44 | 2,420,771,484.88 | 2,469,785,308.07 | 2,471,584,976.31 |
| 流动负债: | | | | |
| 短期借款 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 应付票据及应付账款 | 226,089,882.91 | 191,734,965.35 | 213,094,120.68 | 261,503,730.93 |
| 其中：应付票据 | - | - | 5,172,114.56 | 5,172,114.56 |
| 应付账款 | 226,089,882.91 | 191,734,965.35 | 207,922,006.12 | 256,331,616.37 |
| 合同负债 | 37,797,702.98 | 24,943,542.25 | 16,047,074.96 | 28,071,729.93 |
| 应付职工薪酬 | 1,335,171.26 | 1,359,657.53 | 2,074,341.56 | 3,029,454 |
| 应交税费 | 11,020,288.4 | 31,738,139.66 | 27,616,187.15 | 23,682,905.38 |
| 其他应付款合计 | 64,899,818.36 | 39,293,071.77 | 47,898,581.98 | 64,395,548.97 |
| 一年内到期的非流动负债 | 14,597,301.99 | 13,440,758.33 | 14,742,375.4 | 14,861,168.66 |
| 其他流动负债 | 31,751,346.95 | 12,277,738.09 | 48,255,999.88 | 3,662,344.8 |
| 流动负债合计 | 397,491,512.85 | 324,787,872.98 | 379,728,681.61 | 409,206,882.67 |
| 非流动负债: | | | | |
| 长期借款 | 3,000,000 | 3,800,000 | 1,800,000 | - |
| 租赁负债 | 1,338,702.96 | 1,226,399.12 | 1,049,303.61 | 1,354,973.17 |
| 长期应付款 | - | - | 13,200,000 | 13,200,000 |
| 递延收益 | 246,975,363.52 | 252,485,995.22 | 256,096,626.91 | 251,894,755.27 |
| 递延所得税负债 | 2,802,235.02 | 3,365,429.36 | 2,931,262.53 | 1,965,378.07 |
| 非流动负债合计 | 254,116,301.5 | 260,877,823.7 | 275,077,193.05 | 268,415,106.51 |
| 负债合计 | 651,607,814.35 | 585,665,696.68 | 654,805,874.66 | 677,621,989.18 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 510,657,000 | 510,657,000 | 510,657,000 | 510,657,000 |
| 资本公积 | 337,393,806.93 | 337,393,806.93 | 337,393,806.93 | 337,378,624.27 |
| 其他综合收益 | 32,159 | 9,689.99 | 9,689.99 | 192,780.92 |
| 专项储备 | 952,250.19 | 952,250.19 | 952,250.19 | 1,134,763.8 |
| 盈余公积 | 126,006,345.3 | 126,006,345.3 | 126,006,345.3 | 119,928,027.47 |
| 未分配利润 | 838,845,929.65 | 834,252,962.53 | 814,869,202.34 | 799,950,645.14 |
| 归属于母公司股东权益合计 | 1,813,887,491.07 | 1,809,272,054.94 | 1,789,888,294.75 | 1,769,241,841.6 |
| 少数股东权益 | 24,954,069.02 | 25,833,733.26 | 25,091,138.66 | 24,721,145.53 |
| 股东权益合计 | 1,838,841,560.09 | 1,835,105,788.2 | 1,814,979,433.41 | 1,793,962,987.13 |
| 负债和股东权益合计 | 2,490,449,374.44 | 2,420,771,484.88 | 2,469,785,308.07 | 2,471,584,976.31 |
| 公告日期 | 2025-08-27 | 2025-04-26 | 2025-04-26 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |